HopeStage
Back to all studies
UnknownNCT04829253

Effectiveness of Short and Telematic Version of Cognitive-behavioral Treatment in Borderline Personality Disorder

This study has an unknown status in Chile. It is testing Short and Telematic Version of Cognitive-behavioral Treatment for Borderline Personality Disorder.

Personality disorders, Borderline personalityBehavioralFrom 18 Years to 65 Years
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 65 years.

Listed locations
Santiago, ChileSee all locations and recruitment

Compensation and expense reimbursement have not been verified for this summary.

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateEstimated: November 2021
Recruitment status
Unknown
Enrollment listed in the registry
240
Sponsor
Pontificia Universidad Catolica de Chile
Sponsor type
Unknown or unclear
Study type
Behavioral
Intervention type
Psychotherapy / behavioral intervention
Study phase
Not clearly listed
Locations
Chile
Age range
From 18 Years to 65 Years
Official registry ID
NCT04829253
Official title
Effectiveness of a Short and Telematic Version of Cognitive-behavioral Treatment for Borderline Personality Disorder: an Open-label, Non-inferiority Randomized Clinical

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT04829253. We help you review the study, but cannot decide medical eligibility.

Recruitment & locations

Status unknown

Santiago

Registry details
Registry conditions (original wording)

Borderline Personality Disorder

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Pontificia Universidad Catolica de Chile.

Who can participate?

Listed age limits: 18 years to 65 years.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me